Nearly here … generic Viagra (sildenafil) for all …

On Monday December 11 (next week) phase I of the availability of generic Viagra will kick in (here in the US), and those of us who need / want this product to help cope with ED should see a roughly 50 percent drop in the price … READ MORE …

OTC Viagra coming to the UK … soon-ish

Prostate cancer patients in the UK may want to know (if they don’t already) that the erectile dysfunction drug sildenafil (Viagra) will become available as an “over the counter” or OTC drug called Viagra Connect early next year. … READ MORE …

US FDA approves first generic version of Viagra

In what may be an important piece of information for many men with prostate cancer, the U.S. Food and Drug Administration yesterday approved the first generic form of the erectile dysfunction drug sildenafil or Viagra. … READ MORE …

Delaying onset of erectile dysfunction when receiving radiation therapy

Daily treatment with sildenafil citrate (Viagra) seems to have been able to help maintain erectile function for up to 2 years among men receiving such adjuvant treatment during and after radiotherapy for localized prostate cancer. … READ MORE …

Pfizer’s patent for Viagra expires today … in Europe

According to a story on the FiercePharma web site, the patent for sildenafil (Viagra) will expire today in Europe. This ought to lead to a significant drop in the price for a very popular drug as generic equivalents rapidly come available. Here in the USA, however, Pfizer has managed to extend the patent for Viagra to 2020 (through litigation).

 

Small study shows no long-term benefit in preventing loss of erectile function

Data from a newly-published (but very small) randomized, double-blind, placebo-controlled clinical trial show no significant, clinical impact of sildenafil (Viagra®) taken once daily as a treatment to optimize retention of erectile function at up to 2 years after radiation therapy for localized prostate cancer. … READ MORE …

Sildenafil citrate, erectile function, and radiation therapy for localized prostate cancer

According to data to be presented this afternoon at the annual meeting of the American Society for Radiation Oncology (ASTRO), a double-blind, randomized, placebo-controlled clinical trial has shown that sildenafil citrate can be used to improve sexual function of prostate cancer patients treated with radiation therapy. … READ MORE …